Cargando…

LRRK2 interactions with α-synuclein in Parkinson’s disease brains and in cell models

Mutations in the genes encoding leucine-rich repeat kinase 2 (LRRK2) and α-synuclein are associated with both autosomal dominant and idiopathic forms of Parkinson’s disease (PD). α-Synuclein is the main protein in Lewy bodies, hallmark inclusions present in both sporadic and familial PD. We show tha...

Descripción completa

Detalles Bibliográficos
Autores principales: Guerreiro, Patrícia Silva, Huang, Yue, Gysbers, Amanda, Cheng, Danni, Gai, Wei Ping, Outeiro, Tiago Fleming, Halliday, Glenda Margaret
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer-Verlag 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3611031/
https://www.ncbi.nlm.nih.gov/pubmed/23183827
http://dx.doi.org/10.1007/s00109-012-0984-y
_version_ 1782264527092449280
author Guerreiro, Patrícia Silva
Huang, Yue
Gysbers, Amanda
Cheng, Danni
Gai, Wei Ping
Outeiro, Tiago Fleming
Halliday, Glenda Margaret
author_facet Guerreiro, Patrícia Silva
Huang, Yue
Gysbers, Amanda
Cheng, Danni
Gai, Wei Ping
Outeiro, Tiago Fleming
Halliday, Glenda Margaret
author_sort Guerreiro, Patrícia Silva
collection PubMed
description Mutations in the genes encoding leucine-rich repeat kinase 2 (LRRK2) and α-synuclein are associated with both autosomal dominant and idiopathic forms of Parkinson’s disease (PD). α-Synuclein is the main protein in Lewy bodies, hallmark inclusions present in both sporadic and familial PD. We show that in PD brain tissue, the levels of LRRK2 are positively related to the increase in α-synuclein phosphorylation and aggregation in affected brain regions (amygdala and anterior cingulate cortex), but not in the unaffected visual cortex. In disease-affected regions, we show co-localization of these two proteins in neurons and Lewy body inclusions. Further, in vitro experiments show a molecular interaction between α-synuclein and LRRK2 under endogenous and over-expression conditions. In a cell culture model of α-synuclein inclusion formation, LRRK2 co-localizes with the α-synuclein inclusions, and knocking down LRRK2 increases the number of smaller inclusions. In addition to providing strong evidence for an interaction between LRRK2 and α-synuclein, our results shed light on the complex relationship between these two proteins in the brains of patients with PD and the underlying molecular mechanisms of the disease. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s00109-012-0984-y) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-3611031
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Springer-Verlag
record_format MEDLINE/PubMed
spelling pubmed-36110312013-04-01 LRRK2 interactions with α-synuclein in Parkinson’s disease brains and in cell models Guerreiro, Patrícia Silva Huang, Yue Gysbers, Amanda Cheng, Danni Gai, Wei Ping Outeiro, Tiago Fleming Halliday, Glenda Margaret J Mol Med (Berl) Original Article Mutations in the genes encoding leucine-rich repeat kinase 2 (LRRK2) and α-synuclein are associated with both autosomal dominant and idiopathic forms of Parkinson’s disease (PD). α-Synuclein is the main protein in Lewy bodies, hallmark inclusions present in both sporadic and familial PD. We show that in PD brain tissue, the levels of LRRK2 are positively related to the increase in α-synuclein phosphorylation and aggregation in affected brain regions (amygdala and anterior cingulate cortex), but not in the unaffected visual cortex. In disease-affected regions, we show co-localization of these two proteins in neurons and Lewy body inclusions. Further, in vitro experiments show a molecular interaction between α-synuclein and LRRK2 under endogenous and over-expression conditions. In a cell culture model of α-synuclein inclusion formation, LRRK2 co-localizes with the α-synuclein inclusions, and knocking down LRRK2 increases the number of smaller inclusions. In addition to providing strong evidence for an interaction between LRRK2 and α-synuclein, our results shed light on the complex relationship between these two proteins in the brains of patients with PD and the underlying molecular mechanisms of the disease. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s00109-012-0984-y) contains supplementary material, which is available to authorized users. Springer-Verlag 2012-11-27 2013-04 /pmc/articles/PMC3611031/ /pubmed/23183827 http://dx.doi.org/10.1007/s00109-012-0984-y Text en © Springer-Verlag Berlin Heidelberg 2012
spellingShingle Original Article
Guerreiro, Patrícia Silva
Huang, Yue
Gysbers, Amanda
Cheng, Danni
Gai, Wei Ping
Outeiro, Tiago Fleming
Halliday, Glenda Margaret
LRRK2 interactions with α-synuclein in Parkinson’s disease brains and in cell models
title LRRK2 interactions with α-synuclein in Parkinson’s disease brains and in cell models
title_full LRRK2 interactions with α-synuclein in Parkinson’s disease brains and in cell models
title_fullStr LRRK2 interactions with α-synuclein in Parkinson’s disease brains and in cell models
title_full_unstemmed LRRK2 interactions with α-synuclein in Parkinson’s disease brains and in cell models
title_short LRRK2 interactions with α-synuclein in Parkinson’s disease brains and in cell models
title_sort lrrk2 interactions with α-synuclein in parkinson’s disease brains and in cell models
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3611031/
https://www.ncbi.nlm.nih.gov/pubmed/23183827
http://dx.doi.org/10.1007/s00109-012-0984-y
work_keys_str_mv AT guerreiropatriciasilva lrrk2interactionswithasynucleininparkinsonsdiseasebrainsandincellmodels
AT huangyue lrrk2interactionswithasynucleininparkinsonsdiseasebrainsandincellmodels
AT gysbersamanda lrrk2interactionswithasynucleininparkinsonsdiseasebrainsandincellmodels
AT chengdanni lrrk2interactionswithasynucleininparkinsonsdiseasebrainsandincellmodels
AT gaiweiping lrrk2interactionswithasynucleininparkinsonsdiseasebrainsandincellmodels
AT outeirotiagofleming lrrk2interactionswithasynucleininparkinsonsdiseasebrainsandincellmodels
AT hallidayglendamargaret lrrk2interactionswithasynucleininparkinsonsdiseasebrainsandincellmodels